Examiner: KOSAR, ANDREW D

Tech Center 1600 • Art Units: 1600 1622 1625 1654

This examiner grants 41% of resolved cases

Performance Statistics

41.4%

Allow Rate

-18.6% vs TC avg

280

Total Applications

+31.8%

Interview Lift

1271

Avg Prosecution Days

Based on 263 resolved cases, 2023–2026

3.5%

§101 Eligibility

20.3%

§102 Novelty

27.1%

§103 Obviousness

30.5%

§112 Clarity

App #	Title	Status	Assignee
18034661	THERAPEUTIC AGENT FOR COVID-19	Non-Final OA	TOHOKU UNIVERSITY
17602103	FUSED TRICYCLIC COMPOUND AND MEDICINAL USE THEREOF	Final Rejection	JAPAN TOBACCO INC.
18299640	USE OF AN IRAK4 MODULATOR FOR GENE THERAPY	Non-Final OA	Genzyme Corporation
18362386	DINUCLEAR PHOSPHANE GOLD(I) COMPLEXES FOR TREATING CANCER	Non-Final OA	Imam Abdulrahman Bin Faisal University

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.